Germany's vaccine rollout has a healthcare.gov problem


Germany was one of the international stars of the early response to the COVID-19 pandemic last year thanks to a renowned contact tracing system that kept infection rates low, but its vaccine rollout is not going so well. So far, the country has only administered 6.2 million doses, well below the 21 million in the United Kingdom, which began its drive a few weeks earlier, but has a smaller population.
One of the big issues is how difficult it is to sign up for an appointment in the first place, at least in some regions of the country. Reports the Financial Times, the registration portal requires 10 online steps, including a two-step authentication process. For months, the website would also only allow people to sign up for one appointment, even though two doses of the vaccines available in Germany are required for full inoculation, and if everything is booked, there's no waiting list people to notify people when more doses become available. "It's totally amateurish and incredibly inflexible," one German health official told FT.
The jumbled nature of the system is giving some Americans "flashbacks" to the highly-anticipated healthcare.gov launch in 2013, which was tainted by a variety of technical difficulties and an incomplete website design that made it challenging for people to sign up for their health insurance. Read more at The Financial Times. Tim O'Donnell
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The week's best photos
In Pictures A human pyramid, a church on wheels, and more
-
The Week Unwrapped: Is it time for a new world map?
Podcast Plus, why is the pope getting flatmates? And why are seagull 'muggings' on the rise?
-
Ford Ranger Plug-in Hybrid: 'more than just a novelty'
The Week Recommends Europe's first plug-in hybrid pickup is 'surprisingly agile'
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC